Market research of drugs used for local treatment of dermatitis
DOI:
https://doi.org/10.24959/uekj.19.23Keywords:
market analysis, medicines, dermatitis, local therapyAbstract
Aim. To make an analysis of drugs, presented on the Ukrainian pharmaceutical market and used for local therapy of dermatitis by pharmacotherapeutic groups, composition, release forms and country
of origin in order to substantiate the necessity of developing a new drug based on biologically active substances of medicinal plant material (MPM).
Results. The analysis of drugs presented on the Ukrainian pharmaceutical market used for local therapy of dermatitis with the exception of groups D01 (Antifungal drugs for use in dermatology), D06 (Antibiotics and chemotherapeutics) and D07 (Corticosteroids) due to the preliminary composition of the drug being developed. The composition of drugs registered in Ukraine was analyzed, depending on the direction of pharmacotherapeutic action and the number of components (mono or combination), their distribution by release form, country of origin, the presence of components.
Conclusions. An assortment analysis of the auxiliary agents used to treat dermatitis has shown a small proportion of medications complex action that will prevent the development of the disease or accelerate the recovery and the lack of means that can simultaneously provide cosmetic skin care. Thus, combined drugs among the studied is only 8 %, based on MPM – 3 %. Over 36 % of the drugs of the studied groups are presented in the form of a solution, 31 % – in the form of an ointment. The products of Ukrainian manufacturers in the studied groups occupy 86 % of the registered drugs. The prospect of further research can be the search for effective components on the basis of MPM to create a drug for the local treatment of manifestations of dermatitis.
References
Statystychni dani za 2017 r. (2017). Tsentr medstatystyky MOZ Ukrainy. Available at: http://medstat.gov.ua/ukr/statdan.html
Nakaz MOZ Ukrainy vid 08.05.2009 № 312. (2009). Pro zatverdzhennia klinichnykh protokoliv nadannia medychnoi dopomohy khvorym na dermatovenerolohichni zakhvoriuvannia. Available at: https://zakon.rada.gov.ua/rada/show/en/v0312282-09
Salimova, I. V., Averina, V. I. (2014). MS, 4, 106–109.
Flohr, C., & Mann, J. (2013). New insights into the epidemiology of childhood atopic dermatitis. Allergy, 69(1), 3–16 https://doi.org/10.1111/all.12270
Sidbury, R., Davis, D. M., Cohen, D. E., Kordoro, K. M., Berger, T. G., … Bergman, J. N. (2014). Guide to the treatment of atopic dermatitis: section 3. Treatment and treatment with phototherapy and system agents. J Am Acad Dermatol, 71, 327–349.
Novak, N., & Simon, D. (2011). Atopic dermatitis - from new pathophysiologic insights to individualized therapy. Allergy, 66(7), 830–839. https://doi.org/10.1111/j.1398-9995.2011.02571.x
Baiva, P. P., Makarova, O. E., Baranova, I. I., & Martynyuk, T. V. (2017). Research of dermatological medicines assortment for treatment of infectious skin diseases. Upravlìnnâ, ekonomìka ta zabezpečennâ âkostì v farmacìï, 4(52), 36–41. https://doi.org/10.24959/uekj.17.36
Zaika, S. V., Bezpala, Y. O., Shmelkova, K. S., & Shmatenko, O. P. (2018). The study of the assorment of dermatological products for the local treatment of seborrheic dermatitis. Socìal’na farmacìâ v ohoronì
zdorov’â, 4(3), 69–79. https://doi.org/10.24959/sphhcj.18.124
Dankevych, O. S., Romakin V. V. (2018). Mekhanizmy rozvytku patolohichnykh protsesiv i khvorob ta yikhnia farmakolohichna korektsiia : tezy dop. I nauk.-prakt. internet-konf. z mizhnar. uchastiu. Kharkiv: NFaU, 82.
Tikhonov, O. I., Bondarenko, L. O., & Shpychak, O. S. (2017). Marketing research of the domestic market of medicines for the local treatment of dry skin. Socìal’na farmacìâ v ohoronì zdorov’â, 3(4), 65–75. https://doi.org/10.24959/sphhcj.17.99
Derzhavnyi reiestr likarskykh zasobiv Ukrainy. (n.d.). Available at: http://www.drlz.com.ua/
Deeva, E. V., Ogorodova, L. M., Deev, I. A., Sheveleva, I. V. (2008). VSP, 2, 55–60.
Smirnova, G. I. (2006). VSP, 2, 50–55.
Downloads
Published
Issue
Section
License
Copyright (c) 2019 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
